New insights into the etiological pathogenesis of Peyronie's disease

被引:1
作者
Hauck, EW [1 ]
Hauptmann, A [1 ]
Haag, SM [1 ]
Weidner, W [1 ]
机构
[1] Univ Giessen, Klin & Poliklin Urol & Kinderurol, D-35385 Giessen, Germany
关键词
Peyronie's disease; etiological pathogenesis; HLA-system; TGF-beta; NO/ROS; cell culture; cytogenetic instability;
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
This paper reviews the current knowledge of the etiological pathogenesis of Peyronie's disease. De la Peyronie himself supposed a connection with venereal diseases. Herein, infectious, traumatic, autoimmune and genetic causes are discussed. An important hypothesis is that the recurrent microtraumatisation of the tunica albuginea during sexual intercourse leads to small lesions that activate processes of wound healing and development of fibrotic plaque. According to recent data, an association with the antigens of the HLA-system could be ruled out. Transforming growth factor beta (TGF-beta) seems to have an important impact due to its increased expression in the plaque. Furthermore it is possible to induce a condition similar to Peyronie's disease by intratunical injection of cytomodulin - a substance with TGF-beta-like activity - in an animal model. As in other fibrotic diseases, an imbalance between nitric oxide (NO) and reactive oxygen species (ROS) seems to be of importance. The most important new insights were gained from cell-culture models in which increased expression of basic fibroblast growth factor (bFGF), as well as a change in cell cycle regulation (p53) and cytogenetic instability were observed.
引用
收藏
页码:387 / 391
页数:5
相关论文
共 50 条
  • [31] Peyronie?s Disease: A Brief Overview
    Feyisetan, Oladapo
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (04)
  • [32] Oral therapy for Peyronie's disease
    Mynderse, LA
    Monga, M
    INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, 2002, 14 (05) : 340 - 344
  • [33] Oral therapy for Peyronie's disease
    L A Mynderse
    M Monga
    International Journal of Impotence Research, 2002, 14 : 340 - 344
  • [34] Results of radiotherapy for Peyronie's disease
    Niewald, M
    von Wenzlawowicz, K
    Fleckenstein, J
    Wisser, L
    Derouet, H
    Rübe, C
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 64 (01): : 258 - 262
  • [35] Objective Assessments of Peyronie's Disease
    Chen, Jessie Y.
    Hockenberry, Mark S.
    Lipshultz, Larry, I
    SEXUAL MEDICINE REVIEWS, 2018, 6 (03) : 438 - 445
  • [36] Surgical Management of Peyronie’s Disease
    Uwais B. Zaid
    Amjad Alwaal
    Xiaoyu Zhang
    Tom F. Lue
    Current Urology Reports, 2014, 15
  • [37] Peyronie's Disease: A Historical Perspective
    Carriere, Stephen P.
    Pytell, Jarratt D.
    Saltzman, Amanda F.
    Fuselier, Harold A.
    AMERICAN JOURNAL OF MENS HEALTH, 2014, 8 (05) : 434 - 439
  • [38] All about Peyronie's disease
    Hussein, Ahmed A.
    Alwaal, Amjad
    Lue, Tom F.
    ASIAN JOURNAL OF UROLOGY, 2015, 2 (02) : 70 - 78
  • [39] Clinical presentations of Peyronie's disease
    J P Pryor
    D J Ralph
    International Journal of Impotence Research, 2002, 14 : 414 - 417
  • [40] Is there a role for proteomics in Peyronie's disease?
    Domes, Trustin
    De Young, Ling
    O'Gorman, David B.
    Gan, Bing Siang
    Bella, Anthony J.
    Brock, Gerald
    JOURNAL OF SEXUAL MEDICINE, 2007, 4 (04) : 867 - 877